Cochlear Valuation

Is COH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of COH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: COH (A$337.52) is trading above our estimate of fair value (A$176.99)

Significantly Below Fair Value: COH is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for COH?

Other financial metrics that can be useful for relative valuation.

COH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue10.1x
Enterprise Value/EBITDA42x
PEG Ratio5.1x

Price to Earnings Ratio vs Peers

How does COH's PE Ratio compare to its peers?

The above table shows the PE ratio for COH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average67.2x
RHC Ramsay Health Care
58.5x18.3%AU$12.9b
SHL Sonic Healthcare
27.9x14.5%AU$14.0b
PME Pro Medicus
155.4x20.1%AU$10.7b
AHC Austco Healthcare
26.9xn/aAU$55.1m
COH Cochlear
63.1x12.3%AU$22.1b

Price-To-Earnings vs Peers: COH is good value based on its Price-To-Earnings Ratio (63.1x) compared to the peer average (67.2x).


Price to Earnings Ratio vs Industry

How does COH's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: COH is expensive based on its Price-To-Earnings Ratio (63.1x) compared to the Global Medical Equipment industry average (28.7x).


Price to Earnings Ratio vs Fair Ratio

What is COH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

COH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio63.1x
Fair PE Ratio33.4x

Price-To-Earnings vs Fair Ratio: COH is expensive based on its Price-To-Earnings Ratio (63.1x) compared to the estimated Fair Price-To-Earnings Ratio (33.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst COH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$337.52
AU$282.20
-16.4%
12.9%AU$365.00AU$220.00n/a17
Mar ’25AU$336.50
AU$281.02
-16.5%
13.5%AU$365.00AU$220.00n/a17
Feb ’25AU$304.87
AU$254.43
-16.5%
13.1%AU$318.46AU$200.00n/a16
Jan ’25AU$298.67
AU$251.45
-15.8%
12.2%AU$318.46AU$200.00n/a17
Dec ’24AU$272.29
AU$241.65
-11.3%
10.6%AU$295.00AU$197.78n/a18
Nov ’24AU$244.27
AU$239.49
-2.0%
9.3%AU$280.00AU$197.78n/a18
Oct ’24AU$255.32
AU$238.98
-6.4%
9.6%AU$280.00AU$197.78n/a18
Sep ’24AU$268.50
AU$238.25
-11.3%
9.8%AU$280.00AU$190.00n/a19
Aug ’24AU$238.87
AU$226.67
-5.1%
9.1%AU$265.00AU$190.00n/a19
Jul ’24AU$229.07
AU$225.49
-1.6%
9.1%AU$265.00AU$190.00n/a19
Jun ’24AU$248.25
AU$225.20
-9.3%
9.2%AU$265.00AU$190.00n/a19
May ’24AU$246.34
AU$224.13
-9.0%
8.9%AU$265.00AU$190.00n/a16
Apr ’24AU$236.69
AU$224.13
-5.3%
8.9%AU$265.00AU$190.00n/a16
Mar ’24AU$223.41
AU$222.06
-0.6%
8.0%AU$250.63AU$190.00AU$336.5017
Feb ’24AU$212.50
AU$216.05
+1.7%
9.9%AU$247.00AU$173.00AU$304.8716
Jan ’24AU$204.12
AU$215.68
+5.7%
10.4%AU$247.00AU$167.00AU$298.6716
Dec ’23AU$213.00
AU$215.62
+1.2%
10.4%AU$247.00AU$167.00AU$272.2916
Nov ’23AU$200.66
AU$214.70
+7.0%
10.2%AU$247.00AU$167.00AU$244.2717
Oct ’23AU$194.54
AU$213.93
+10.0%
10.7%AU$247.00AU$167.00AU$255.3217
Sep ’23AU$213.99
AU$215.36
+0.6%
10.6%AU$247.00AU$167.00AU$268.5017
Aug ’23AU$218.40
AU$213.47
-2.3%
11.4%AU$245.00AU$154.00AU$238.8717
Jul ’23AU$199.63
AU$216.63
+8.5%
11.3%AU$250.36AU$155.00AU$229.0717
Jun ’23AU$221.90
AU$221.15
-0.3%
10.9%AU$250.36AU$155.00AU$248.2518
May ’23AU$231.74
AU$219.89
-5.1%
10.6%AU$250.36AU$155.00AU$246.3418
Apr ’23AU$223.04
AU$218.33
-2.1%
11.5%AU$255.19AU$149.00AU$236.6918
Mar ’23AU$226.73
AU$218.33
-3.7%
11.5%AU$255.19AU$149.00AU$223.4118

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.